Health Economics and Outcomes Research (HEOR) Services

SG Analytics (SGA) uses AI/ML algorithms to provide exact answers when assessing the value of a new treatment or product for reimbursements and healthcare payers. Our HEOR services go beyond basic clinical outcomes by analyzing costs, patient quality of life, and broader societal effects, helping drive evidence-based decisions in both policy and practice.

Get Started

Health economics and outcomes research services

Health Economics & Outcomes Research Services

Daily and favorable health outcomes are analyzed through health economics and outcomes research (HEOR) studies of healthcare providers, clinics, hospitals, managed care, and community health promotion initiatives in various settings.

In 2020, SG Analytics first offered health economics and outcomes research services and solutions. Our pharmaceutical clients consistently rank this service among our most in-demand options. Using machine learning technologies, our health economics and outcomes research experts can scrape accurate real-world data relevant to medical research and disease areas, transforming a time-consuming procedure into a straightforward, white-labeled, unique report.

Why HEOR Services are Important

With each passing day, HEOR gains more and more importance because it aids in the best allocation of healthcare resources by providing vital information to decision-makers in the pharmaceutical, diagnostic, and medical product industries, empowering healthcare professionals and consumers. Suppose a pharmaceutical or biomedical firm wants to get reimbursed in the future for a new treatment, diagnostic kit, product, or other intervention. In that case, they must research health economics outcomes to support their strategy and marketing teams. HEOR reports cost millions of dollars and are notoriously time-consuming and difficult to get.

Why SGA for HEOR Services

Industry Leader

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted life sciences & healthcare business consulting and services provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English (U.S. & U.K.) experts (either in-house or partnerships).

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with the in-house capabilities of primary market research, financial research, data analytics, data engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With

Medical Devices

We support new product entries, competitive intelligence (CI), and market intelligence teams with relevant information.

Pharmaceuticals & Biopharma

We support pharma and biopharma market intelligence, strategy, sales, marketing, and R&D teams in developed and developing markets.

Mergers and Acquisition Analysis

We support M&A firms with product portfolio fitment analysis, patents and clinical trial data, pipeline analysis, and short listing of healthcare acquirer and acquire prospects.

Private Equity, Investment Banks, and Investor Community

We support financial firms with ad-hoc and white-labeled research comprising industry analysis, primary research, and CI intel from major markets.

Animal Health

We offer market intelligence on veterinary products and equipment and help mid-senior management with relevant data.

In Vitro Diagnostics

We track diagnostics kits, reagents, and equipment, which help marketing and sales teams with market penetration efforts. Our services are preferred by product managers and marketing leaders.

Life Sciences & Healthcare IT

We offer technology tracking services, market sizing and forecasting, and primary market research involving healthcare payers and providers and product launch information to life sciences & healthcare IT leaders of the world.

Life Sciences Consulting & Information Service Providers

We have run off-shored capability centers of ISPs, with a record of tracking >5,000 pharmaceutical companies and supporting their onshore teams to track markets and create analyses.